Hsbc Holdings PLC Buys 82,973 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Hsbc Holdings PLC lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 10.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 882,280 shares of the company's stock after buying an additional 82,973 shares during the period. Hsbc Holdings PLC owned about 0.19% of GE HealthCare Technologies worth $69,022,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Fayez Sarofim & Co lifted its holdings in shares of GE HealthCare Technologies by 7.3% during the 4th quarter. Fayez Sarofim & Co now owns 9,150 shares of the company's stock worth $715,000 after acquiring an additional 625 shares during the period. Stifel Financial Corp boosted its holdings in GE HealthCare Technologies by 12.8% during the fourth quarter. Stifel Financial Corp now owns 296,491 shares of the company's stock valued at $23,180,000 after purchasing an additional 33,567 shares in the last quarter. OneDigital Investment Advisors LLC grew its stake in shares of GE HealthCare Technologies by 110.8% in the 4th quarter. OneDigital Investment Advisors LLC now owns 29,081 shares of the company's stock valued at $2,274,000 after purchasing an additional 15,283 shares during the period. TD Waterhouse Canada Inc. raised its holdings in shares of GE HealthCare Technologies by 26.9% in the 4th quarter. TD Waterhouse Canada Inc. now owns 384,228 shares of the company's stock worth $30,031,000 after buying an additional 81,337 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in shares of GE HealthCare Technologies by 104.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 38,136 shares of the company's stock worth $2,981,000 after buying an additional 19,467 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

GEHC has been the topic of several analyst reports. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. BTIG Research set a $95.00 target price on GE HealthCare Technologies and gave the stock a "buy" rating in a report on Monday, April 14th. Piper Sandler dropped their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Finally, Citigroup boosted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and an average target price of $96.50.

GE HealthCare Technologies Stock Up 4.2 %

GE HealthCare Technologies stock traded up $2.86 during midday trading on Wednesday, reaching $70.95. The stock had a trading volume of 4,600,639 shares, compared to its average volume of 3,280,209. The stock has a market capitalization of $32.48 billion, a P/E ratio of 16.35, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. The firm's fifty day simple moving average is $75.62 and its 200-day simple moving average is $81.81. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $4.78 billion during the quarter, compared to the consensus estimate of $4.66 billion. During the same period in the prior year, the business posted $0.90 EPS. The company's quarterly revenue was up 2.7% on a year-over-year basis. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.20%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.